bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.
bioMérieux Dividend Announcement
• bioMérieux announced a annually dividend of $0.93 per ordinary share which will be made payable on 2024-06-11. Ex dividend date: 2024-06-07
• bioMérieux annual dividend for 2024 was $0.93
• bioMérieux annual dividend for 2023 was $0.91
• bioMérieux's trailing twelve-month (TTM) dividend yield is 0.86%
• bioMérieux's payout ratio for the trailing twelve months (TTM) is 24.36%
• bioMérieux's dividend growth over the last five years (2018-2023) was 18.01% year
bioMérieux Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-07 | $0.93 | annually | 2024-06-11 |
2023-06-06 | $0.91 | annually | 2023-06-08 |
2022-06-06 | $0.91 | annually | 2022-06-08 |
2021-06-04 | $0.75 | annually | 2021-06-08 |
2020-07-14 | $0.22 | annually | 2020-07-16 |
2019-06-04 | $0.39 | annually | 2019-06-06 |
2018-06-05 | $0.40 | annually | 2018-06-07 |
bioMérieux Dividend per year
bioMérieux Dividend growth
bioMérieux Dividend Yield
bioMérieux current trailing twelve-month (TTM) dividend yield is 0.86%. Interested in purchasing bioMérieux stock? Use our calculator to estimate your expected dividend yield:
bioMérieux Financial Ratios
bioMérieux Dividend FAQ
Other factors to consider when evaluating bioMérieux as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy bioMérieux stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: bioMérieux's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, bioMérieux publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, bioMérieux distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from bioMérieux are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: bioMérieux sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, bioMérieux distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: bioMérieux declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of bioMérieux's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review bioMérieux's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.